🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Niranjan Khaire presenting our joint proposal with Nora Chokr Mohamed Sorror and Alexandra Gomez A. at the Acute Leukemia Working committee at #Tandem24 #bmtsm

Important questions on sequencing CAR T and Allo in #ALL: 1- Which patients need consolidative Allo after CAR T ? 2- Are responses/toxicity different for patient who receive CAR T with prior Allo - effect of residual donor T cells ? Acute Leukemia Working Committee 🗳️ #Tandem24

#tandem24 #bmtsm Vago: HLA loss much more common in those exposed to GCV. 😯 Other antivirals (foscarnet, letermovir) don’t appear to be mutagenic in this way.

Proud of our amazing fellows and resident Mohammad Alhomoud Joshua Fein and Neela Easwar for sharing our data from WCM Lymphoma Weill Cornell BMT Program WCMHemOncFellow at the Tandem meeting CIBMTR ASTCT

AAACTT-ing together again in San Antonio. Great evening with colleagues and friends. #Tandem24 #bmtsm

Patients with favorable-risk AML who had NPM1 mutation have poor prognosis if they also harbor mutations highly specific for sMut. ow.ly/nXqg50QMWBR #myeloidneoplasia

Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review geriatriconcology.net/article/S1879-… Ashley Rosko William Dale, MD, PhD, FASCO @rochgerionc Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Toxicity #GeriatricAssessment

AAACTT is cordially inviting you to join us in Amman! Our first conference is coming up in July! Exciting topics from experts in the field. Check program highlights below. #bmtsm

Just out Nature Medicine meta-analysis >7600 CAR T pts led by David Cordas dos Santos & Kai Rejeski - Non-relapse mortality post CAR-T = 6.8% - highest w ciltacel (15%) & brexucel (10.6%) - axicel (7%) > tisa-/lisocel (4%) for LBCL - 51% of NRM deaths from infection nature.com/articles/s4159…

Great to see everyone and to make new friends at the first AAACTT conference. Thank you to our wonderful hosts مؤسسة ومركز الحسين للسرطان #bmtsm A Samer Al-Homsi @usamagergis Mohamed Kharfan-Dabaja, MD, MBA Rabi Hanna Dr. Rawad Rihani Mohammad Abu Zaid Monzr M. AlMalki, MD Ayman Saad Razan Mohty Nora Chokr Hasan Hashem

Geriatric vulnerabilities are frequent among older adults evaluated for CAR-T therapy, enabling risk stratification before therapy. ow.ly/oK4250SMbTX #healthservicesandoutcomes #immunobiologyandimmunotherapy

MRD is highly prognostic in #AML and can inform SCT decisions or enrollment into MRD-directed clinical trials. MRD endpoints may also allow for accelerated drug approval in AML. New review by Nicholas Short MD and Richard Dillon in AmericanJournalofHematology doi.org/10.1002/ajh.27… #leusm

Dr Mohamad Mohty elegantly discussing the complex question of donor choice. 👇check the summary slide #ASH24 #ASH24rm ASH

Dr Caitie Gribbin presented incredibly data on the role of follicular dendritic cells and the temporal relationship with FL progression… with actionable targets! Incredible and provocative work, we’re excited to have her join our faculty! WCMHemOncFellow WCM Lymphoma #ASH24

Thanks NewYork-Presbyterian for a fun night on Broadway for Left on Tenth on Broadway. Wonderful to see our Weill Cornell Leukemia team highlighted esp Drs. Gail Roboz & Koen Van Besien. Thanks Delia Ephron for sharing your story! WCMHemOncFellow Joshua Fein Evelyn Orlando Molly Gilligan Leukemia Fighters

Applications for the 2026 Weill Cornell Medicine NewYork-Presbyterian advanced Bone Marrow Transplant (#BMT) and #CellularTherapy fellowship are open. Apply for the opportunity to join our team in July 2026: bit.ly/3JkgMFu

Drs. Alexandra Gomez (Alexandra Gomez A.) and Nora Chokr (Nora Chokr)’s article on the impact of disparities in access to #StemCellTransplant and strategies to promote representation in #PrecisionMedicine was featured in the current special issue of @nature #BMT: bit.ly/4hEeCAG

Congrats Drs. Evelyn Orlando & Herman van Besien for participating in the Lymphoma Research Foundation Lymphoma Scientific Research Mentoring Program (LSRMP). Great opportunity for Hem-Onc Fellows Network to workshop their research protocols w/ lymphoma experts! WCMHemOncFellow Evelyn Orlando Herman van Besien